Rituximab in Neuromyelitis Optica Spectrum Disorders-Reply: Why Not as First-Line Therapy. Reply

Valentina Damato, Amelia Evoli, Raffaele Iorio

Research output: Contribution to journalLetter

Original languageEnglish
Pages (from-to)482-483
Number of pages2
JournalJAMA Neurology
Volume74
Issue number4
DOIs
Publication statusPublished - Apr 1 2017

ASJC Scopus subject areas

  • Clinical Neurology

Cite this